articleTop 10% cited
Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy
Gastrointestinal Endoscopy · 1991 · Vol. 37(4) · pp. 421–427
Janet B. Arrowsmith(United States Food and Drug Administration)B. Burt Gerstman(Georgetown University Medical Center)David E. Fleischer(Georgetown University Medical Center)Stanley B. Benjamin✉(United States Food and Drug Administration)
Esophageal and GI PathologyColorectal Cancer Screening and DetectionGastric Cancer Management and OutcomesMedicineFood and drug administrationEndoscopyDrugGastroenterologyInternal medicineGeneral surgeryPharmacology
MeSH terms
AgedCholangiopancreatography, Endoscopic RetrogradeDiazepamFemaleHeart DiseasesHumansInjections, IntravenousMaleMidazolamMiddle AgedLaparoscopyRespiration DisordersRetrospective StudiesEndoscopy, GastrointestinalConscious Sedation
Funding
- U.S. Food and Drug Administration
Citations
497
FWCI
10.50
field-weighted impact
References
11
Percentile
99%
vs. same field & year
Citations per year
Cited by
A lexicon for endoscopic adverse events: report of an ASGE workshop
Gastrointestinal Endoscopy · 2010 · 2,385 citations
A national study of cardiopulmonary unplanned events after GI endoscopy
Gastrointestinal Endoscopy · 2007 · 424 citations
Clinical Policy: Procedural Sedation and Analgesia in the Emergency Department
Annals of Emergency Medicine · 2014 · 640 citations
References
Modeling and variable selection in epidemiologic analysis.
American Journal of Public Health · 1989 · 2,216 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.